1973Archives of Internal MedicineRequires access

Hypogonadotropic Hypogonadism With Anosmia—Kallmann's Syndrome

James L. Males

Open publisher page 29 citations

Abstract

Clinical observations, hormonal measurements, and olfactory tests have been performed in six patients (five male, one female) with hypogonadotropic hypogonadism and anosmia—Kallmann's syndrome. All were deficient in gonadotropins and all had an obvious decrease in their primary and secondary sex characteristics. All were verified as anosmic. One patient had a craniotomy, and agenesis of the olfactory bulbs was identified. Although the five male patients had normal basal 17-hydroxycorticosteroid (17-OHCS) levels, administration of metyrapone in two of them failed to lead to the predicted rise in these levels, suggesting a defective pituitary reserve. A disorder of hypothalamic dysfunction is suggested, involving the control of releasing factors with hypogonadism and anosmia as the clinical markers. Our experience suggests that the syndrome is not rare and that all hypogonadal patients should be questioned about their sense of smell.

About this research paper

What this paper is about

Clinical observations, hormonal measurements, and olfactory tests have been performed in six patients (five male, one female) with hypogonadotropic hypogonadism and anosmia—Kallmann's syndrome. All were deficient in gonadotropins and all had an obvious decrease in their primary and secondary sex characteristics. All were verified as anosmic. One patient had a craniotomy, and agenesis of the olfactory bulbs was identified. Although the five male patients had normal basal 17-hydroxycorticosteroid (17-OHCS) levels, administration of metyrapone in two of them failed to lead to the predicted rise in these levels, suggesting a defective pituitary reserve. A disorder of hypothalamic dysfunction is suggested, involving the control of releasing factors with hypogonadism and anosmia as the clinical markers. Our experience suggests that the syndrome is not rare and that all hypogonadal patients should be questioned about their sense of smell.

Why it matters

OpenAlex reports 29 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Clinical observations, hormonal measurements, and olfactory tests have been performed in six patients (five male, one female) with hypogonadotropic hypogonadism and anosmia—Kallmann's syndrome. All were deficient in gonadotropins and all had an obvious decrease in their primary and secondary sex characteristics. All were verified as anosmic. One patient had a craniotomy, and agenesis of the olfactory bulbs was identified. Although the five male patients had normal basal 17-hydroxycorticosteroid (17-OHCS) levels, administration of metyrapone in two of them failed to lead to the predicted rise in these levels, suggesting a defective pituitary reserve. A disorder of hypothalamic dysfunction is suggested, involving the control of releasing factors with hypogonadism and anosmia as the clinical markers. Our experience suggests that the syndrome is not rare and that all hypogonadal patients should be questioned about their sense of smell.

Key concepts: Anosmia, Hypogonadotropic hypogonadism, Kallmann syndrome, Medicine, Hypothalamic disease, Endocrinology, Internal medicine, Hormone

Related papers

Back to paper searchBrowse research topicsOriginal source
Hypogonadotropic Hypogonadism With Anosmia—Kallmann's Syndrome — Research Paper | ScholarLens